# SEQUELLA INC.: Form D filings

SEQUELLA INC., a pharmaceuticals company in Rockville, MD, filed 12 Form D notices with the SEC between 2009 and 2017. The latest, on October 10, 2017, reports $630,589 sold of a $3.6 million offering to 6 investors.

Find out what SEQUELLA INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20SEQUELLA%20INC.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=SEQUELLA%20INC.&page=%2Fdata%2Fform-d%2Fcompany%2Fsequella-inc-1065544)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20SEQUELLA%20INC.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=SEQUELLA%20INC.&page=%2Fdata%2Fform-d%2Fcompany%2Fsequella-inc-1065544)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Maryland](https://specstream.ai/data/form-d/state/maryland): 608 rows, by operating companies, filed since November 1, 2024, $30.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/maryland
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 9610 MEDICAL CENTER DR, SUITE 200, Rockville, MD, 20850
- Phone: (301) 762-7776
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1065544

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Oct 10, 2017 | New notice | $3,624,753 | $630,589 | $2,994,164 | 6 | Sep 7, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1065544/000106554417000001/0001065544-17-000001-index.htm) |
| Sep 22, 2016 | New notice | $940,942 | $940,942 | $0 | 9 | Aug 3, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1065544/000106554416000002/0001065544-16-000002-index.htm) |
| Sep 22, 2016 | New notice | $3,006,250 | $1,724,250 | $1,282,000 | 9 | Aug 3, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1065544/000106554416000001/0001065544-16-000001-index.htm) |
| Oct 10, 2014 | New notice | $3,100,000 | $3,100,000 | $0 | 36 | Sep 26, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1065544/000149155214000002/0001491552-14-000002-index.htm) |
| Oct 1, 2013 | New notice | $2,400,000 | $555,000 | $1,845,000 | 3 | Aug 28, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1065544/000106554413000001/0001065544-13-000001-index.htm) |
| Sep 4, 2012 | New notice | $3,000,000 | $100,000 | $2,900,000 | 2 | Aug 22, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1065544/000106554412000001/0001065544-12-000001-index.htm) |
| Nov 4, 2011 | New notice | $3,000,000 | $50,000 | $2,950,000 | 2 | Oct 19, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1065544/000106554411000003/0001065544-11-000003-index.htm) |
| Aug 10, 2011 | New notice | $4,000,000 | $550,000 | $3,450,000 | 5 | Aug 1, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1065544/000106554411000002/0001065544-11-000002-index.htm) |
| Jun 2, 2011 | New notice | $1,500,000 | $1,000,000 | $500,000 | 1 | May 13, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1065544/000106554411000001/0001065544-11-000001-index.htm) |
| Feb 22, 2010 | New notice | $6,000,000 | $2,000,000 | $4,000,000 | 1 | Feb 16, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1065544/000106554410000001/0001065544-10-000001-index.htm) |
| Aug 20, 2009 | New notice | $1,800,000 | $1,500,000 | $300,000 | 4 | Aug 6, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1065544/000106554409000004/0001065544-09-000004-index.htm) |
| Jul 9, 2009 | New notice | $720,097 | $720,097 | $0 | 1 | Jun 15, 2008 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1065544/000106554409000003/0001065544-09-000003-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| MARK I. RAMPY | Executive Officer |  |
| LAWRENCE I. MILLER | Executive Officer |  |
| RONALD I. MELTZER | Director |  |
| CAROL A. NACY | Executive Officer, Director |  |
| DAVID I. MCNEELEY | Executive Officer |  |
| LEO A. EINCK | Executive Officer, Director |  |
| BRADLEY I. ROTTER | Director |  |
| JOHN I. FRIEDMAN | Director |  |
| PAIGE I. MACDONALD | Director |  |

[Every Form D from the week of Oct 9, 2017](https://specstream.ai/data/form-d/week/2017-10-09) · [All recent filings in Maryland](https://specstream.ai/data/form-d/state/maryland) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what SEQUELLA INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).